Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

The supplied review concerns Alzheimer’s disease rather than ALS or MND

Original source

Mitochondrial homeostasis dysregulation: Potential mechanisms of Alzheimer's disease mediated by TDP-43.Ageing Res Rev · 6 August 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Study type
Review
Studied in
Human, Animal, Cells

Article

View article on the publisher's site (opens in a new tab)via the publisher — full text availability varies

Related topics

The review examines how TDP-43 pathology may disrupt mitochondrial homeostasis in Alzheimer’s disease. It does not report a finding or decision about amyotrophic lateral sclerosis (ALS) or motor neurone disease (MND).

Why this matters

This source does not provide evidence that would change treatment, diagnosis or understanding of ALS/MND.

Limitations and context

Only one source was supplied, and it is a review about Alzheimer’s disease, not primary research into ALS/MND. It therefore cannot support an ALS/MND news story.

Summarised by Compass 8 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?